Demyelinating disease in a patient with psoriatic arthritis and family history of multiple sclerosis treated with infliximab.
Ruiz-Jimeno
Teresa
T
Carvajal
Alejandra
A
Mata
Cristina
C
Aurrecoechea
Elena
E
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D003711:Demyelinating Diseases / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D005192:Family Health; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000235:genetics*; D012307:Risk Factors; D013116:Spinal Cord / Q000473:pathology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab